Shukra Pharmaceuticals has witnessed a remarkable surge in its stock price, with shares rising by an astounding 166% over the past month. As of January 10, 2025, the stock closed at ₹184.45, marking a significant milestone, as the stock reached its 52-week high on the same day.
Over the past month, Shukra Pharmaceuticals has been one of the standout performers in the stock market, posting impressive gains that have captured the attention of investors. Here’s a summary of the stock’s performance (as per Investing) over the last month:
| Date | Price | Open | High | Low | Change % |
|---|---|---|---|---|---|
| Jan 10, 2025 | ₹184.45 | ₹177.25 | ₹184.45 | ₹177.25 | +1.99% |
| Jan 09, 2025 | ₹180.85 | ₹180.85 | ₹180.85 | ₹180.85 | +1.97% |
| Jan 08, 2025 | ₹177.35 | ₹177.35 | ₹177.35 | ₹177.35 | +1.98% |
| Jan 07, 2025 | ₹173.90 | ₹173.90 | ₹173.90 | ₹173.90 | +4.98% |
| Jan 06, 2025 | ₹165.65 | ₹165.65 | ₹165.65 | ₹158.55 | +4.97% |
| Jan 03, 2025 | ₹157.80 | ₹157.80 | ₹157.80 | ₹157.80 | +4.99% |
| Jan 02, 2025 | ₹150.30 | ₹150.30 | ₹150.30 | ₹150.25 | +4.99% |
| Jan 01, 2025 | ₹143.15 | ₹143.15 | ₹143.15 | ₹142.05 | +4.97% |
| Dec 31, 2024 | ₹136.37 | ₹135.00 | ₹136.37 | ₹135.00 | +5.00% |
| Dec 30, 2024 | ₹129.88 | ₹125.90 | ₹129.88 | ₹121.50 | +5.00% |
| Dec 27, 2024 | ₹123.70 | ₹123.70 | ₹123.70 | ₹119.00 | +5.00% |
| Dec 26, 2024 | ₹117.81 | ₹112.20 | ₹117.81 | ₹106.59 | +5.00% |
| Dec 24, 2024 | ₹112.20 | ₹112.20 | ₹112.20 | ₹112.20 | +5.00% |
| Dec 23, 2024 | ₹106.86 | ₹106.86 | ₹106.86 | ₹106.86 | +4.99% |
| Dec 20, 2024 | ₹101.78 | ₹101.78 | ₹101.78 | ₹101.78 | +4.99% |
| Dec 19, 2024 | ₹96.94 | ₹96.94 | ₹96.94 | ₹96.94 | +4.99% |
| Dec 18, 2024 | ₹92.33 | ₹92.26 | ₹92.33 | ₹90.17 | +4.99% |
| Dec 17, 2024 | ₹87.94 | ₹86.38 | ₹87.94 | ₹80.00 | +9.99% |
| Dec 16, 2024 | ₹79.95 | ₹78.45 | ₹79.95 | ₹76.25 | +9.99% |
| Dec 13, 2024 | ₹72.69 | ₹67.89 | ₹73.02 | ₹67.50 | +9.49% |
| Dec 12, 2024 | ₹66.39 | ₹70.48 | ₹70.49 | ₹66.00 | -3.92% |
| Dec 11, 2024 | ₹69.10 | ₹72.35 | ₹73.00 | ₹66.85 | -2.57% |
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
